18th May 2012 07:00
18 May 2012 Source BioScience plc ('Source BioScience' or 'the Company') Notice of AGM and Annual Report
Source BioScience announces that its 2012 Annual General Meeting will be held at the Company's registered offices, 1 Orchard Place, Nottingham Business Park, Nottingham NG8 6PX at 10.30 am on 13 June 2012. Formal notice of this meeting is available on the website and has been posted to shareholders together with a copy of the 2011 Annual Report and Accounts, a copy of which can be downloaded from the Source BioScience website - www.sourcebioscience.com .
A copy of the 2011 Annual Report and Accounts has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.hemscott.com/nsm.do.
-- ENDS --
For further information, please contact:
Source BioScience plcNick AshChief Executive OfficerTel: +44 (0)115 973 9010www.sourcebioscience.com
For investor and media enquiries:
N+1 Brewin (Financial Advisor, Sponsor and Broker)Aubrey Powell/Luke BoyceTel: +44 (0)203 201 3710www.nplus1brewin.comCollege Hill (PR Agency to Source BioScience)Melanie Toyne-Sewell/Jayne CrookTel: +44 (0)207 457 2020Mob: +44( 0)7890 022814 / +44 (0)7979 462044Email: [email protected]
About Source BioScience:
Source BioScience plc is an international diagnostics and genetic analysis business serving the healthcare and research markets. The LifeSciences division provides core laboratory research support from conceptualisation to implementation, calling upon a wide range of cutting-edge technology platforms including an online catalogue of biomolecular tools. The Group is a trusted provider of a complete range of sophisticated microarray, next generation and conventional DNA sequencing services. GLP, GCP and CPA accreditations also make our full range of services very attractive for applications in regulatory studies and clinical settings. The Healthcare division provides screening and reference laboratory diagnostic testing for cancer and other diseases and additional predictive testing for treatment optimisation for clinicians and patients. The Group has its headquarters in Nottingham, UK with additional laboratory facilities in Oxford, Cambridge, Dublin and Berlin. Further information about Source BioScience can be found at www.sourcebioscience.com.
UKMAT:12000878.3 1 UKMAT:12000878.3
XLONRelated Shares:
SBS.L